A Randomized, Double-blind, Placebo Controlled Study to Assess Efficacy, Safety and Tolerability of LCQ908 in Subjects With Familial Chylomicronemia Syndrome
Clinical trial NCT01514461 · COMPLETED
Trial details
- NCT number
- NCT01514461
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2014-05-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.